Among chemotherapeutic drugs used widely for patients with breast cancers, 5-fluorouracil (targeting thymidylate synthase and DNA synthesis), doxorubicin (targeting topoisomerase II), and paclitaxel (targeting cytoskeleton structure tubulin) are three well-defined first-line agents [17, 18]. Here, TYMS is linked to breast cancer.